Afferent renal nerves (ARNs) convey signals generated by physiological changes in the kidney to the central nervous system. The aim of this study was to determine whether ARNs contribute to ...

Initial evidence of the existence of renin, which is an angiotensinogenase enzyme secreted by the kidney, was presented to the medical community more than 100 years ago. Nevertheless, the significance ...

Renin–angiotensin system (RAS) inhibitors — including angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) — slow the progression of mild or moderate chronic kidney ...

Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...

The renin-angiotensin-aldosterone system (RAAS), or renin-angiotensin-system (RAS) is a regulator of blood pressure and cardiovascular function. Dysregulated RAAS is implicated in high blood pressure, ...

Most of us are unaware when the ANS is at work. Its functions are involuntary and reflexive, such as changing the size of blood vessels or causing our hearts to beat faster. Scientists are well aware ...

A new study has identified a critical "pressure sensor" inside the kidney that helps the body control blood pressure and ...

Researchers recently reported a preliminary signal of possible structural damage in the kidneys of six patients after long-term treatment with a renin-angiotensin system (RAS) inhibitor, a superclass ...

Chronic hyperkalemia is prevalent among patients with chronic kidney disease, heart failure or other conditions treated with renin–angiotensin–aldosterone system (RAAS) inhibitors, and has been ...

The clinical use of sodium glucose co-transporter 2 inhibitors (SGLT2) represents a recent advance in the treatment of diabetes. Accumulating evidence suggests that these drugs may reduce the risk for ...